Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–3 of 3 results
Advanced filters: Author: "Katarzyna Smietana" Clear advanced filters

  • This analysis of the industry's clinical-stage portfolio in the past two decades reveals several trends, including a recent improvement in success rates in late-stage trials, an increase in overall portfolio size and higher success rates for biologics and partnered projects.

    • Katarzyna Smietana
    • Marcin Siatkowski
    • Martin Møller
    Comments & Opinion
    Nature Reviews Drug Discovery
    Volume: 15, P: 379-380

  • Analysis of industry pipeline data and revenue forecasts highlights several trends in the anticipated output of new drugs and the therapeutic area focus over the next 5 years, including a growth in the average number of new drug approvals annually.

    • Roy Berggren
    • Martin Møller
    • Katarzyna Smietana
    Comments & Opinion
    Nature Reviews Drug Discovery
    Volume: 11, P: 435-436